Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- CombiMatrix and Arizona State University
- CombiMatrix and Arizona State University's Biodesign Institute are developing a peptide array synthesizer.
- Research articles 2005-11-15
- CombiMatrix CEO Dr. Amit Kumar Scheduled to Appear on CNBC
- NEWPORT BEACH, Calif. -- Acacia Research Corporation (Nasdaq:CBMX) (Nasdaq:ACTG) announced today that Dr. Amit Kumar, CEO and President of CombiMatrix, is scheduled to appear on CNBC's "Kudlow & Cramer", today December 20th. The hour-long show, which features the business and economic impact of the day's major news stories along with...
- Research articles 2004-12-20
- CombiMatrix announced in July that it will receive an additional $2.3 million from the US Department of Defense
- CombiMatrix announced in July that it will receive an additional $23 million from the US Department of Defense for the development of a sensor system and biochip technology to monitor for biological and chemical agents.
- Research articles 2004-10-15
- CombiMatrix will work with Case Western Reserve University
- * CombiMatrix will work with Case Western Reserve University to develop a novel diagnostic for Alzheimer's disease using its CustomArray platform.
- Research articles 2004-06-15
- The US Department of Defense awarded CombiMatrix a $5.9 million two-year contract
- * The US Department of Defense awarded CombiMatrix a $5.9 million two-year contract to develop its microarray technology for detection of biological threats by integrating microelectronics, microfluidics and automation.
- Research articles 2004-05-31
- The University of Washington is using CombiMatrix' customizable microarrays to develop nucleic acid based tests for diagnosing lymphoma
- The University of Washington is using CombLMatrix' customizable microarrays to develop nucleic acid based tests for diagnosing lymphoma. Also, CombiMatrix has signed a research and collaboration agreement with RationalDiagnostics to commercialize related produce.
- Research articles 2003-11-15
- CombiMatrix Completes $5.5 Million in Milestones in Strategic Alliance with Roche
- Business Editors/Health/Medical Writers BIOWIRE2K NEWPORT BEACH, Calif.--BUSINESS WIRE--Dec. 2, 2002 Acacia Research Corporation (Nasdaq:ACRI) announced today that its subsidiary, CombiMatrix, has completed a number of additional R&D milestones in its strategic alliance with Roche Applied Science. Completion of these milestones will result in additional payments to CombiMatrix...
- Research articles 2002-12-02
- CombiMatrix Completes Milestone in Strategic Alliance with Roche
- Business Editors & Health/Medical Writers BIOWIRE2K Acacia Research Corporation (Nasdaq:ACRI) announced today that its majority owned subsidiary, CombiMatrix, has completed a milestone in its strategic alliance with Roche Applied Science. CombiMatrix's strategic alliance with Roche includes a collaboration for the development and commercialization of CombiMatrix's DNA microarray...
- Research articles 2002-07-16
- CombiMatrix and the CBRC of Japan Enter Into a Technology Access and Purchase Agreement
- Business Editors & Health/Medical Writers BIOWIRE2K NEWPORT BEACH, Calif.--BW HealthWire--April 26, 2002 Acacia Research Corporation (Nasdaq:ACRI) announced today that its subsidiary CombiMatrix Corporation's Japanese subsidiary, has entered into a technology access and purchase agreement in Japan with the Computational Biology Research Center, a division of the Japanese...
- Research articles 2002-04-26
- Acacia Research Announces Plan to Create Separate Nasdaq Listed Public Shares for Its CombiMatrix and Acacia Technologies Businesses
- Business Editors & Health/Medical Writers BIOWIRE2K NEWPORT BEACH, Calif.--BW HealthWire--March 20, 2002 Acacia Research Corporation (Nasdaq:ACRI) announced today that its Board of Directors has approved a plan to divide its common stock into two new classes -- new "CombiMatrix" stock, that would reflect the performance of its...
- Research articles 2002-03-20
- CombiMatrix Corporation Receives Grant from National Institutes of Health for Continued Development of Its Protein Biochip Technology
- Business Editors & Health/Medical Writers BIOWIRE2K MUKILTEO, Wash.--BW HealthWire--Feb. 20, 2002 CombiMatrix Corporation, a majority owned subsidiary of Acacia Research Corporation (Nasdaq:ACRI), announced today that it has been awarded a Phase I NIH grant for the development of its protein biochip technology. The title of the...
- Research articles 2002-02-20
- Acacia Research Subsidiary, CombiMatrix, Completes Major Milestone in Strategic Alliance with Roche
- Business Editors PASADENA, Calif.--BUSINESS WIRE--Jan. 8, 2002 Acacia Research Corporation (Nasdaq:ACRI) announced today that its majority owned subsidiary, CombiMatrix, has completed a major milestone in its strategic alliance with Roche Applied Science. CombiMatrix has demonstrated several key performance metrics of its custom in-situ microarray system. CombiMatrix is...
- Research articles 2002-01-08
- CombiMatrix' Bio-Warfare Detection Technology Published in the Current Issue of Analytica Chimica Acta
- Business Editors/Health & Medical Writers BIOWIRE2K MUKILTEO, Wash.--BW HealthWire--Oct. 16, 2001 CombiMatrix Corporation, a majority owned subsidiary of Acacia Research Corp. (Nasdaq:ACRI) announced today the publication of an article describing advances that the company has made in detection of bio-warfare agents using CombiMatrix' biochips (Analytica Chimca Acta,...
- Research articles 2001-10-16
- CombiMatrix To Present at UBS Warburg Global Sciences Conference
- Business Editors/Health & Medical Writers BIOWIRE2K PASADENA, Calif.--BW HealthWire--Oct. 2, 2001 Acacia Research Corporation (Nasdaq:ACRI) announced today that its majority-owned subsidiary, CombiMatrix Corporation, will be presenting at the UBS Warburg Global Life Sciences Conference in New York at 10:40 a.m. on Oct. 9, 2001. For more...
- Research articles 2001-10-02
- CombiMatrix to Present At Bear Stearns Annual Healthcare Conference and J.P. Morgan H&Q's Annual Genomics Conference
- Business Editors & Health/Medical Writers BIOWIRE2K PASADENA, Calif.--BW HealthWire--Sept. 5, 2001 Acacia Research Corporation (Nasdaq:ACRI) today announced that its majority-owned subsidiary, CombiMatrix Corporation, will be presenting at the Bear Stearns 14th Annual Healthcare Conference on Wednesday, September 12, 2001. CombiMatrix will also present at the J.P....
- Research articles 2001-09-05
- NASA Licenses CombiMatrix's Biochip Technology for Biological Research in Space
- Business Editors & Health/Medical/Aerospace Writers BIOWIRE2K PASADENA, Calif.--BW HealthWire--Aug. 8, 2001 Acacia Research Corporation (Nasdaq:ACRI) today announced that its majority-owned subsidiary, CombiMatrix Corporation, has entered into a license and supply agreement with the National Aeronautics and Space Administration NASA. The agreement provides for the license, purchase...
- Research articles 2001-08-08
- Acacia Research Increases Ownership of CombiMatrix Corporation to 61.4 Percent
- Business Editors PASADENA, Calif.--BUSINESS WIRE--June 28, 2000 Acacia Research Corporation (Nasdaq/NMS:ACRI) announced today that it has increased its ownership of privately held CombiMatrix Corporation from 51.8 percent to 61.4 percent. Acacia Research acquired the additional ownership position from existing shareholders of CombiMatrix in exchange for approximately 489,000 restricted...
- Research articles 2000-06-28
- Acacia Research Affiliate CombiMatrix Raises $17.5 Million in Equity Financing
- Business Editors PASADENA, Calif.--BUSINESS WIRE--March 7, 2000 Acacia Research Corporation (Nasdaq:ACRI) announced today that affiliate CombiMatrix Corporation has raised $17.5 million in equity financing. Acacia Research participated in the financing and owns 52% of CombiMatrix. CombiMatrix's biochip system has the potential to offer significant advantages over current...
- Research articles 2000-03-07
- Acacia Research Subsidiary, CombiMatrix, Names Medical Industry Executive Gerald Knudson as Chief Executive Officer
- Business Editors &Health/Medical Writers PASADENA, Calif.--BUSINESS WIRE--Feb. 4, 2000 Acacia Research Corp. (Nasdaq:ACRI) announced today that subsidiary CombiMatrix Corp. has named medical industry executive Gerald Knudson as its President and Chief Executive Officer. Knudson, who will also serve as a member of the Board of Directors, has...
- Research articles 2000-02-04
Additional Resources
- CombiMatrix opens facility at MaRS
- CombiMatrix Molecular Diagnostics CMDX is expanding its operations with the creation of a new facility at the MaRS Discovery District in Toronto. CMDX is the wholly owned subsidiary of CombiMatrix Group, one of two operating divisions of Acacia ResearchCombiMatrix Molecular Diagnostics CMDX is expanding its operations with the creation of...
- Research articles 2006-04-28
- << Previous
- page 1 of 1
- Next >>
